000 | 01832 a2200505 4500 | ||
---|---|---|---|
005 | 20250514212815.0 | ||
264 | 0 | _c20050214 | |
008 | 200502s 0 0 eng d | ||
022 | _a0145-2126 | ||
024 | 7 |
_a10.1016/j.leukres.2004.06.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTakeuchi, Kazuto | |
245 | 0 | 0 |
_aExpression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-alpha. _h[electronic resource] |
260 |
_bLeukemia research _cFeb 2005 |
||
300 |
_a173-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBone Marrow Cells _xcytology |
650 | 0 | 4 |
_aGene Expression Regulation, Leukemic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdiagnosis |
650 | 0 | 4 | _aMethylation |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 |
_aRepressor Proteins _xanalysis |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSuppressor of Cytokine Signaling 3 Protein |
650 | 0 | 4 | _aSuppressor of Cytokine Signaling Proteins |
650 | 0 | 4 |
_aTranscription Factors _xanalysis |
700 | 1 | _aSakai, Ikuya | |
700 | 1 | _aNarumi, Hirosi | |
700 | 1 | _aYasukawa, Masaki | |
700 | 1 | _aKojima, Kensuke | |
700 | 1 | _aMinamoto, Yoko | |
700 | 1 | _aFujisaki, Tomoaki | |
700 | 1 | _aTanimoto, Kazushi | |
700 | 1 | _aHara, Masamichi | |
700 | 1 | _aNumata, Akihiko | |
700 | 1 | _aGondo, Hisashi | |
700 | 1 | _aTakahashi, Masuhiro | |
700 | 1 | _aFujii, Nobuharu | |
700 | 1 | _aMasuda, Kozo | |
700 | 1 | _aFujita, Shigeru | |
773 | 0 |
_tLeukemia research _gvol. 29 _gno. 2 _gp. 173-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2004.06.006 _zAvailable from publisher's website |
999 |
_c15289351 _d15289351 |